Edition:
United Kingdom

People: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

127.73USD
23 Aug 2019
Change (% chg)

$-3.54 (-2.70%)
Prev Close
$131.27
Open
$131.07
Day's High
$131.22
Day's Low
$127.14
Volume
4,272,948
Avg. Vol
2,103,348
52-wk High
$148.97
52-wk Low
$122.00

Doudna, Jennifer 

Dr. Jennifer A Doudna, Ph.D., is the Independent Director of the Company. She has joined the faculty at University of California, Berkeley, as a Professor of Biochemistry & Molecular Biology in 2002. She directs the Innovative Genomics Institute, a joint UC Berkeley-UC San Francisco center, holds the Li Ka Shing Chancellor’s Professorship in Biomedicine and Health, and is the chair of the Chancellor’s Advisory Committee on Biology at UC Berkeley. Dr. Doudna is Principal Investigator at the Doudna Lab at UC Berkeley and has founded and serves on the scientific advisory boards of Caribou Biosciences, Inc. and Intellia Therapeutics, Inc., both leading CRISPR genome engineering companies. She has been an Investigator with the Howard Hughes Medical Institute since 1997. Dr. Doudna is the recipient of numerous scientific awards in biochemistry and genetics, including: the Alan T. Waterman Award (2000); the Eli Lilly Award in Biological Chemistry of the American Chemical Society (2001); a co-recipient of the Breakthrough Prize in Life Sciences (2015); a co-recipient of the Gruber Prize in Genetics (2015); a co-recipient of the Canada Gairdner International Award (2016); the Heineken Prize for Biochemistry and Biophysics (2016); the Tang Prize (2016); the Japan Prize (2017); and the Albany Medical Center Prize (2017). Dr. Doudna was elected to the National Academy of Sciences (2002); the American Academy of Arts and Sciences (2003); the National Academy of Medicine (2010); the National Academy of Inventors (2014); and as a Foreign Member of the Royal Society (2016). Dr. Doudna is a Trustee for Pomona College.

Basic Compensation

Total Annual Compensation, USD 78,768
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 78,768

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alex Gorsky

20,097,600

Paulus Stoffels

10,591,800

Joaquin Duato

9,283,960

Joseph Wolk

2,708,190

Peter Fasolo

3,621,280

Michael Ullmann

5,336,150
As Of  31 Dec 2018